Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Abnormality, Heart

dehydroepiandrosterone sulfate has been researched along with Abnormality, Heart in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer-Chicko, C; Baird, GL; Barr, RG; Bluemke, DA; Foderaro, AE; Fritz, JS; Hill, NS; Kawut, SM; Klinger, JR; Lima, JAC; Mullin, CJ; Ouyang, P; Palevsky, HI; Palmisicano, AJ; Pinder, D; Preston, IR; Roberts, KE; Smith, KA; Ventetuolo, CE; Walsh, T; Whittenhall, M1

Other Studies

1 other study(ies) available for dehydroepiandrosterone sulfate and Abnormality, Heart

ArticleYear
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
    The European respiratory journal, 2018, Volume: 51, Issue:6

    Topics: Aged; Body Mass Index; Case-Control Studies; Connective Tissue Diseases; Dehydroepiandrosterone Sulfate; Estradiol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Male; Middle Aged; Postmenopause; Proportional Hazards Models; Risk Factors; Walk Test

2018